TARGETED MOLECULES CORPORATION

Targeted Molecules Corporation (TMC) is a privately held biopharmaceutical company located in San Diego, California. The Company was founded in 2000 to discover and commercialize targeted drug therapies for a broad range of ailments including cancer and diseases of the central nervous system (CNS). To fulfill this mission, TMC utilizes a patented in vivo drug discovery platform to identify, optimize, and validate the efficacy of lead molecules. This revolutionary approach yields novel molecul... es, precisely targeted to a disease tissue of interest, in a fraction of the time and cost of using traditional in vitro-based methods. TMC received its first invested capital through the establishment of a joint venture with Elan Corporation plc in October 2000. The focus of this collaboration is the development of targeted drugs for the treatment of cancer. In December 2001, we completed a first closing of a $10 million Series B venture financing. Participating investors included Trian Equities (Vancouver); GeneChem Ventures (Montreal); IngleWood Ventures (San Diego); FAT Capital (Taiwan); and GC&H Investments (San Francisco).More